Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. agreed to acquire 9% of stake in Charmacy Pharmaceutical Co., Ltd. (SEHK:2289) from Yao Chuanglong for HKD 70.9 million on September 13, 2022. The transaction is subject to approval of state-owned assets supervisory authority and SAMR. Guotai Junan Capital acted as financial advisor to Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.4 HKD | +7.78% | +3.60% | +11.11% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+11.11% | 185M | |
-30.37% | 15.82B | |
-22.51% | 12.65B | |
-22.88% | 6.6B | |
+11.76% | 6.3B | |
-6.01% | 6.11B | |
+64.02% | 4.75B | |
-1.17% | 4.69B | |
-5.58% | 4.02B | |
-7.87% | 3.59B |
- Stock Market
- Equities
- 2289 Stock
- News Charmacy Pharmaceutical Co., Ltd.
- Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. agreed to acquire 9% of stake in Charmacy Pharmaceutical Co., Ltd. from Yao Chuanglong for HKD 70.9 million.